Sep 09, 2021 / 05:15PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
Hello, everyone. Thanks for joining us on day 1 of our healthcare conference. I'm Tejas Savant, and I cover the Life Science tools and Diagnostics sector here at Morgan Stanley. I'm delighted to have Catalent join us today. And representing the company is Tom Castellano, CFO. Welcome, Tom. Before we get started, I just want to run through some important disclosures. Please see the research disclosure website for Morgan Stanley at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.
With that, Tom, do you want to just go through your safe harbor quickly, and then we can begin?
Thomas P. Castellano - Catalent, Inc. - Senior VP & CFO
Yes, love to. Thanks, Tejas, for the time. Happy to be here. Looking forward to today's discussion. And just a reminder that I may make some forward-looking statements here today, and I would just draw your attention to the risk factors that were recently -- included in our recently filed 10-K that we
Catalent Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers